Explore more publications!
Oklahoma Healthcare Wire
Got News to Share?

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 10, 2025

Accrete Health Partners Launches Partnership with Atalan to Co-develop Groundbreaking Patient Experience Intelligence Module
December 10, 2025

Accrete Health Partners Launches Partnership with Atalan to Co-develop Groundbreaking Patient Experience Intelligence Module

Indeterminate GlobeNewswire
Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis
December 10, 2025

Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis

Indeterminate GlobeNewswire
NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
December 10, 2025

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

Indeterminate GlobeNewswire
Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America
December 10, 2025

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

Indeterminate GlobeNewswire
JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
December 10, 2025

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Indeterminate GlobeNewswire
Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025

Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility

Indeterminate GlobeNewswire
Bioxodes raises €5.5 million Series A extension to continue preparations for pivotal trial of breakthrough stroke candidate
December 10, 2025

Bioxodes raises €5.5 million Series A extension to continue preparations for pivotal trial of breakthrough stroke candidate

Indeterminate GlobeNewswire
Bioxodes lève 5,5 millions d'euros dans le cadre d'une extension de la Série A afin de poursuivre la préparation d’un essai pivot pour son candidat-médicament innovant dans le traitement de l'AVC
December 10, 2025

Bioxodes lève 5,5 millions d'euros dans le cadre d'une extension de la Série A afin de poursuivre la préparation d’un essai pivot pour son candidat-médicament innovant dans le traitement de l'AVC

Indeterminate GlobeNewswire
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
December 10, 2025

Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

Indeterminate GlobeNewswire
New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD
December 10, 2025

New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD

Indeterminate GlobeNewswire
Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025

Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering
December 10, 2025

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

Indeterminate GlobeNewswire
Terns Announces Pricing of Upsized $650 Million Public Offering
December 10, 2025

Terns Announces Pricing of Upsized $650 Million Public Offering

Indeterminate GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants
December 10, 2025

Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants

Indeterminate GlobeNewswire
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 10, 2025

Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock
December 10, 2025

Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
J-Star Announces Approval of Dual Class Share Structure by Shareholders
December 10, 2025

J-Star Announces Approval of Dual Class Share Structure by Shareholders

Indeterminate GlobeNewswire
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
December 10, 2025

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

Indeterminate GlobeNewswire
Over 20 Studies of InnoCare’s Orelabrutinib Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 10, 2025

Over 20 Studies of InnoCare’s Orelabrutinib Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions